LexDanaLexDanabeta
Inventor

Rolf E. Swenson

Inventor
Princeton, NJ, US

Overview

56→
Patents
1994–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 56 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides19%
C07CAcyclic or carbocyclic compounds7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
C07DHeterocyclic compounds5%
Y02ATechnologies for adaptation to climate change5%
Y02PClimate change mitigation technologies in the production or processing of goods4%
C07BGeneral methods of organic chemistry2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
10,995,004Method for functionalizing carbon nanoparticles and compositions20219,663,511'Sphingosine 1-phosphate receptor antagonists'20179,446,155'KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy'20169,408,926'KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy'20169,381,258'Targeting vector-phospholipid conjugates'20169,333,272'Fibrin binding peptide conjugates for diagnostic and therapeutic applications'20169,295,737'Targeting vector-phospholipid conjugates'20169,056,138'Multivalent constructs for therapeutic and diagnostic applications'20158,663,603'Multivalent constructs for therapeutic and diagnostic applications'20148,642,010'KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy'20148,632,753'Multivalent constructs for therapeutic and diagnostic applications'20148,623,822'KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy'20148,551,450'Targeting vector-phospholipid conjugates'20138,466,107'Fibrin-binding peptides and conjugates thereof'20138,444,954'Gastrin releasing peptide compounds'20138,420,050'Gastrin releasing peptide compounds'20138,420,053'Gastrin releasing peptide compounds'20138,414,864'Gastrin releasing peptide compounds'20138,293,214'Targeting and therapeutic compounds and gas-filled microvesicles comprising said compounds'20128,278,274'Fibrin-binding peptides and conjugates thereof'20128,105,567'Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy'20127,989,417'Linkers for radiopharmaceutical compounds'20117,985,402'Targeting vector-phospholipid conjugates'20117,922,998'Gastrin releasing peptide compounds'20117,910,088'Multivalent constructs for therapeutic and diagnostic applications'20117,893,223'Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy'20117,854,919'Multivalent constructs for therapeutic and diagnostic applications'20107,850,947'Gastrin releasing peptide compounds'20107,794,693'Targeting vector-phospholipid conjugates'20107,666,979'Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same'20107,611,692'Gastrin releasing peptide compounds'20097,582,280'Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications'20097,422,733'Linkable sialyl Lewis X analogs'20087,407,644'Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications'20087,261,876'Multivalent constructs for therapeutic and diagnostic applications'20077,226,577'Gastrin releasing peptide compounds'20077,211,240'Multivalent constructs for therapeutic and diagnostic applications'20077,211,382'Primer extension using modified nucleotides'20076,355,490'Attached tags for use in combinatorial chemistry synthesis'20026,310,095'Inhibitors of protein isoprenyl transferases'20016,274,385'Attached tags for use in combinatorial chemistry synthesis'20016,204,293'Inhibitors of protein isoprenyl transferases'20015,981,521'Tetrahydroisoquinoline derivatives as LHRH antagonists'19995,698,522'6-position modified decapeptide LHRH antagonists'19975,616,759'Cyclohexylidene compounds'19975,597,932'Intermediate for the preparation of 19-nor vitamin D compounds'19975,581,006'Synthesis of 19-nor vitamin D compounds'19965,563,286'Synthesis of 19-nor vitamin D compounds'19965,516,759'LHRH antagonists having lactam groups at the N-terminus'19965,502,035'N-terminus modified analogs of LHRH'19965,491,217'LHRH antagonists having modified aminoacyl residues at positions 5 and 6'19965,486,636'Synthesis of 19-nor vitamin D compounds'19965,432,263'Process for producing peptides with side chains containing imidazolinylamino, tetrahydropyrimidinylamino, or alkylguanidinyl groups'19955,413,990'N-terminus modified analogs of LHRH'19955,391,755'Synthesis of 19-NOR vitamin D compounds'19955,281,731'Synthesis of 19-nor vitamin D compounds'1994

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1994–1997Based in Lake Bluff, IL, US· patent location history
1995–2002Based in Grayslake, IL, US· patent location history
2007–2016Patents assigned to BRACCO IMAGING SPA (14)· patent assignee history
2007–2016Patents assigned to DYAX CORP (9)· patent assignee history
2007–2016Based in Princeton, NJ, US· patent location history
2010–2016Patents assigned to BRACCO SUISSE SA (14)· patent assignee history
2012–2016Patents assigned to SWENSON ROLF E (14)· patent assignee history
2012–2016Patents assigned to RAMALINGAM KONDAREDDIAR (10)· patent assignee history
2017Based in Silver Spring, MD, US· patent location history
2021Based in Bethesda, MD, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BRACCO IMAGING SPA142007–2016
BRACCO SUISSE SA142010–2016
SWENSON ROLF Eself142012–2016
RAMALINGAM KONDAREDDIAR102012–2016
DYAX CORP92007–2016
Locations
LocationPatentsSpan
Princeton, New Jersey, US352007–2016
Grayslake, Illinois, US101995–2002
Lake Bluff, Illinois, US71994–1997
Bethesda, Maryland, US12021
Silver Spring, Maryland, US12017